GCP
ZVRA icon

GSA Capital Partners’s Zevra Therapeutics ZVRA Stock Holding History

GSA Capital Partners’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-54,397
Closed -$517K – 2152
2025
Q3 		$517K Buy
+54,397
New +$546K 0.04% 830
2022
Q4 		– Sell
-20,220
Closed -$126K – 1957
2022
Q3 		$126K Buy
20,220
+3,792
+23% +$21.5K 0.02% 1328
2022
Q2 		$73K Sell
16,428
-67,524
-80% -$308K 0.01% 1258
2022
Q1 		$422K Buy
+83,952
New +$534K 0.06% 652

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return